Authors:
De Jonge, ETM
Lindeque, BG
Burger, W
Nesland, JM
Holm, R
Citation: Etm. De Jonge et al., Predicting response to neoadjuvant chemotherapy in patients with cervical carcinoma: can we do without any longer?, INT J GYN C, 10(2), 2000, pp. 137-142
Authors:
Bironaite, D
Nesland, JM
Dalen, H
Risberg, B
Byrne, M
Citation: D. Bironaite et al., N-glycans influence the in vitro adhesive and invasive behaviour of three metastatic cell lines, TUMOR BIOL, 21(3), 2000, pp. 165-175
Authors:
Berner, HS
Davidson, B
Berner, A
Risberg, B
Nesland, JM
Citation: Hs. Berner et al., Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells andreactive mesothelial cells in effusions, VIRCHOWS AR, 436(4), 2000, pp. 330-335
Citation: Ik. Bukholm et Jm. Nesland, Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas, VIRCHOWS AR, 436(3), 2000, pp. 224-228
Authors:
Baekelandt, M
Holm, R
Nesland, JM
Trope, CG
Kristensen, GB
Citation: M. Baekelandt et al., Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer, J CL ONCOL, 18(22), 2000, pp. 3775-3781
Authors:
Berner, HS
Davidson, B
Berner, A
Risberg, B
Kristensen, GB
Trope, CG
Van de Putte, G
Nesland, JM
Citation: Hs. Berner et al., Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications, CLIN EXP M, 18(2), 2000, pp. 197-202
Authors:
Baekelandt, MM
Holm, R
Nesland, JM
Trope, CG
Kristensen, GB
Citation: Mm. Baekelandt et al., P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer, ANTICANC R, 20(2B), 2000, pp. 1061-1067
Citation: Zh. Suo et Jm. Nesland, Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features, ULTRA PATH, 24(6), 2000, pp. 371-381
Authors:
Davidson, B
Gotlieb, WH
Ben-Baruch, G
Kopolovic, J
Goldberg, I
Nesland, JM
Berner, A
Bjamer, A
Bryne, M
Citation: B. Davidson et al., Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases - A clinicopathologic study, GYNECOL ONC, 77(1), 2000, pp. 35-43
Authors:
Davidson, B
Berner, A
Nesland, JM
Risberg, B
Kristensen, GB
Trope, CG
Bryne, M
Citation: B. Davidson et al., Carbohydrate antigen expression in primary tumors, metastatic lesions, andserous effusions from patients diagnosed with epithelial ovarian carcinoma: Evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions, HUMAN PATH, 31(9), 2000, pp. 1081-1087
Authors:
Davidson, B
Berner, A
Nesland, JM
Risberg, B
Berner, HS
Trope, CG
Kristensen, GB
Bryne, M
Florenes, VA
Citation: B. Davidson et al., E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions, J PATHOLOGY, 192(4), 2000, pp. 460-469
Authors:
Bukholm, IK
Nesland, JM
Borresen-Dale, AL
Citation: Ik. Bukholm et al., Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients, J PATHOLOGY, 190(1), 2000, pp. 15-19
Authors:
Risberg, B
Davidson, B
Dong, HP
Nesland, JM
Berner, A
Citation: B. Risberg et al., Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings, J CLIN PATH, 53(7), 2000, pp. 513-517
Authors:
Reed, W
Hannisdal, E
Boehler, PJ
Gundersen, S
Host, H
Nesland, JM
Citation: W. Reed et al., The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma - A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years, CANCER, 88(4), 2000, pp. 804-813
Authors:
Kvalheim, G
Pharo, A
Holte, H
Lenschow, E
Wang, MY
Erikstein, B
Kvaloy, S
Nesland, JM
Smeland, E
Citation: G. Kvalheim et al., Stem cell isolation with immunomagnetic beads and tumor cell contamination, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 291-302
Authors:
Borgen, E
Naume, B
Nesland, JM
Kvalheim, G
Beiske, K
Fodstad, O
Diel, I
Solomayer, EF
Theocharous, P
Coombes, RC
Smith, BM
Wunder, E
Marolleau, JP
Garcia, J
Pantel, K
Citation: E. Borgen et al., Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells, CYTOTHERAPY, 1(5), 1999, pp. 377-388
Authors:
Baekelandt, M
Holm, R
Trope, CG
Nesland, JM
Kristensen, GB
Citation: M. Baekelandt et al., Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study, CLIN CANC R, 5(10), 1999, pp. 2848-2853
Authors:
de Jonge, ETM
Viljoen, E
Lindeque, BG
Amant, F
Nesland, JM
Holm, R
Citation: Etm. De Jonge et al., The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy, INT J GYN C, 9(3), 1999, pp. 198-205
Authors:
Raabe, NK
Sauer, T
Erichsen, A
Nesland, JM
Fossaa, SD
Citation: Nk. Raabe et al., Breast cancer in the contralateral breast: Incidence and histopathology after unilateral radical treatment of the first breast cancer, ONCOL REP, 6(5), 1999, pp. 1001-1007
Authors:
Kristensen, VN
Andersen, TI
Erikstein, B
Geitvik, G
Skovlund, E
Nesland, JM
Borresen-Dale, AL
Citation: Vn. Kristensen et al., Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients (vol 8, pg 441, 1998), PHARMACOGEN, 9(1), 1999, pp. 129-129
Authors:
Bjerkehagen, B
Dietrich, C
Reed, V
Micci, F
Saeter, G
Berner, A
Nesland, JM
Heim, S
Citation: B. Bjerkehagen et al., Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17) (q22;q11), VIRCHOWS AR, 435(5), 1999, pp. 524-530
Authors:
Reed, W
Florenes, VA
Holm, R
Hannisdal, E
Nesland, JM
Citation: W. Reed et al., Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients, VIRCHOWS AR, 435(2), 1999, pp. 116-124
Authors:
Baekelandt, M
Holm, R
Trope, CG
Nesland, JM
Kristensen, GB
Citation: M. Baekelandt et al., The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer, ANN ONCOL, 10(11), 1999, pp. 1335-1341
Authors:
Baekelandt, M
Kristensen, GB
Nesland, JM
Trope, CG
Holm, R
Citation: M. Baekelandt et al., Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 inadvanced ovarian cancer, J CL ONCOL, 17(7), 1999, pp. 2061-2068